Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 3 , Pages 354-360 , June 2008

Sex-Related Differences in Outcome After High-Risk Vascular Surgery After the Administration of β-Adrenergic–Blocking Drugs

  • Robina Matyal, MD

      Affiliations

    • Department of Anesthesia and Critical Care and Pain Management, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
    • Corresponding Author InformationAddress reprint requests to Robina Matyal, MD, Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, CC-470, Deaconess 1, Boston, MA 02215.
    • ,
  • Feroze Mahmood, MD

      Affiliations

    • Department of Anesthesia and Critical Care and Pain Management, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
    • ,
  • Peter Panzica, MD

      Affiliations

    • Department of Anesthesia and Critical Care and Pain Management, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
    • ,
  • Frank Pomposelli, MD

      Affiliations

    • Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
    • ,
  • Kyung W. Park, MD

      Affiliations

    • Department of Anesthesia and Critical Care and Pain Management, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
    • ,
  • Allen Hamden, MD

      Affiliations

    • Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
    • ,
  • Mark Schermerhorn, MD

      Affiliations

    • Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
    • ,
  • Philip Hess, MD

      Affiliations

    • Department of Anesthesia and Critical Care and Pain Management, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

References 

  1. Mangano DT, Wong MG, London MJ, et al. Perioperative myocardial ischemia in patients undergoing noncardiac surgery—II: Incidence and severity during the 1st week after surgery (The Study of Perioperative Ischemia (SPI) Research Group). J Am Coll Cardiol. 1991;17:851–857
  2. Raby KE, Goldman L, Creager MA, et al. Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med. 1989;321:1296–1300
  3. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery (Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group). N Engl J Med. 1999;341:1789–1794
  4. Raby KE, Barry J, Creager MA, et al. Detection and significance of intraoperative and postoperative myocardial ischemia in peripheral vascular surgery. JAMA. 1992;268:222–227
  5. Mackey WC, Fleisher LA, Haider S, et al. Perioperative myocardial ischemic injury in high-risk vascular surgery patients: Incidence and clinical significance in a prospective clinical trial. J Vasc Surg. 2006;43:533–538
  6. Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: Clinical applications. JAMA. 2002;287:1445–1447
  7. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353:349–361
  8. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery (Multicenter Study of Perioperative Ischemia Research Group). N Engl J Med. 1996;335:1713–1720
  9. Hannan EL, Bernard HR, Kilburn HC, et al. Gender differences in mortality rates for coronary artery bypass surgery. Am Heart J. 1992;123:866–872
  10. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293–1304
  11. White WB, Johnson MF, Black HR, et al. Gender and age effects on the ambulatory blood pressure and heart-rate responses to antihypertensive therapy. Am J Hypertens. 2001;14:1239–1247
  12. Luzier AB, Killian A, Wilton JH, et al. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Clin Pharmacol Ther. 1999;66:594–601
  13. Schaefer BM, Caracciolo V, Frishman WH, et al. Gender, ethnicity, and genes in cardiovascular disease (Part 2: Implications for pharmacotherapy). Heart Dis. 2003;5:202–214
  14. Gleiter CH, Gundert-Remy U. Gender differences in pharmacokinetics. Eur J Drug Metab Pharmacokinet. 1996;21:123–128
  15. Kando JC, Yonkers KA, Cole JO. Gender as a risk factor for adverse events to medications. Drugs. 1995;50:1–6
  16. Meibohm B, Beierle I, Derendorf H. How important are gender differences in pharmacokinetics?. Clin Pharmacokinet. 2002;41:329–342
  17. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery–Executive Summary (A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)). Anesth Analg. 2002;94:1052–1064
  18. Slogoff S, Keats AS. Does perioperative myocardial ischemia lead to postoperative myocardial infarction?. Anesthesiology. 1985;62:107–114
  19. Fletcher A, Beevers DG, Bulpitt C, et al. Beta-adrenoceptor blockade is associated with increased survival in male but not female hypertensive patients: A report from the DHSS Hypertension Care Computing Project (DHCCP). J Hum Hypertens. 1988;2:219–227
  20. Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg. 1999;88:477–482
  21. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta-blockers in noncardiac surgery? (Systematic review and meta-analysis of randomised controlled trials). BMJ. 2005;331:313–321
  22. Boersma E, Poldermans D, Bax JJ, et al. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA. 2001;285:1865–1873
  23. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489–497
  24. Stone JG, Foex P, Sear JW, et al. Myocardial ischemia in untreated hypertensive patients: Effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology. 1988;68:495–500
  25. Wallace A, Layug B, Tateo I, et al. McSPI Research Group Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology. 1998;88:7–17
  26. Wiesbauer F, Schlager O, Domanovits H, et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity: A systematic review and meta-analysis. Anesth Analg. 2007;104:27–41
  27. Yang H, Raymer K, Butler R, et al. The effects of perioperative beta-blockade: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J. 2006;152:983–990
  28. Garg R, Yusuf S Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273:1450–1456
  29. Levin RI. The puzzle of aspirin and sex. N Engl J Med. 2005;352:1366–1368
  30. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med. 2002;347:1403–1411
  31. Walle T, Walle UK, Cowart TD, et al. Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects. Clin Pharmacol Ther. 1989;46:257–263
  32. Lim JG, Shapiro EP, Vaidya D, et al. Sex differences in left ventricular function in older persons with mild hypertension. Am Heart J. 2005;150:934–940

PII: S1053-0770(07)00405-3

doi: 10.1053/j.jvca.2007.12.021

Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 3 , Pages 354-360 , June 2008

Article Tools

* Image Usage & Resolution